General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

American Journal of Psychiatry

1996 (153):9, 1185-1188


Suicidal Behavior in Schizophrenia and Its Relationship to Awareness of Illness
Amador XF; Friedman JH; Kasapis C; Yale SA; Flaum M & Gorman JM.

RELEVANCE FOR EARLY INTERVENTION

Most clinicians believe that poor insight in patients with schizophrenia, though problematic for treatment adherence, may be protective with respect to suicide. The assumption is that patients who do not believe that they are ill are less likely to be suicidal. Alternatively, those patients with schizophrenia who recognize and acknowledge the illness will be more suicidal.

This study found that only awareness of particular symptoms was correlated to increased suicidal thoughts and behavior. Contrary to clinical lore, awareness of having an illness was not associated with increased suicidal thoughts or behavior. Patients who have poor insight into having an illness and are not taking their prescribed medication are just as likely to become suicidal as any other person with schizophrenia.

Estimates are that as many as one out of every ten persons with this illness will kill themselves. This study suggests that poor insight into having an illness is not a protective factor as previously believed and argue against the strategy of leaving such patients who refuse treatment to fend for themselves.


general resources | legal resources | medical resources | briefing papers | state activity   
hospital closures | preventable tragedies | press room | search | home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.

Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)